an 8week, Multi-Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Fixed Dose, Dose-Finding Study to Assess the Efficacy and Safety of SK3530 [mirodenafil] in Patients With Erectile Dysfunction.

Trial Profile

an 8week, Multi-Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Fixed Dose, Dose-Finding Study to Assess the Efficacy and Safety of SK3530 [mirodenafil] in Patients With Erectile Dysfunction.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 20 Nov 2006

At a glance

  • Drugs Mirodenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors SK Chemicals
  • Most Recent Events

    • 20 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top